The present invention relates to antagonist antibodies that specifically bindto Notch 3 and inhibit its activation. The present invention includes antibodiesbinding to a conformational epitope comprising the first Lin12 domain and thesecond dimerization domain. The present invention also includes uses of theseantibodies to treat or prevent Notch 3 related diseases or disorders.